CoChat

Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice

Open access

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

The cJun N-terminal kinases (JNKs; JNK1, JNK2, and JNK3) promote degenerative processes after neuronal injury and in disease. JNK2 and JNK3 have been shown to promote retinal ganglion cell (RGC) death after optic nerve injury. In their absence, long-term survival of RGC somas is significantly increased after mechanical optic nerve injury. In glaucoma, because optic nerve damage is thought to be a major cause of RGC death, JNKs are an important potential target for therapeutic intervention. To assess the role of JNK2 and JNK3 in an ocular hypertensive model of glaucoma, null alleles of Jnk2 and Jnk3 were backcrossed into the DBA/2J (D2) mouse. JNK activation occurred in RGCs following increased intraocular pressure in D2 mice. However, deficiency of both Jnk2 and Jnk3 together did not lessen optic nerve damage or RGC death. These results differentiate the molecular pathways controlling cell death in ocular hypertensive glaucoma compared with mechanical optic nerve injury. It is further shown that JUN, a pro-death component of the JNK pathway in RGCs, can be activated in glaucoma in the absence of JNK2 and JNK3. This implicates JNK1 in glaucomatous RGC death. Unexpectedly, at younger ages, Jnk2-deficient mice were more likely to develop features of glaucomatous neurodegeneration than D2 mice expressing Jnk2. This appears to be due to a neuroprotective effect of JNK2 and not due to a change in intraocular pressure. The Jnk2-deficient context also unmasked a lesser role for Jnk3 in glaucoma. Jnk2 and Jnk3 double knockout mice had a modestly increased risk of neurodegeneration compared with mice only deficient in Jnk2. Overall, these findings are consistent with pleiotropic effects of JNK isoforms in glaucoma and suggest caution is warranted when using JNK inhibitors to treat chronic neurodegenerative conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-018-0705-8

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 JNK pathway genes associated with axon injury in RGCs are expressed and activated during D2 glaucoma at 9 months of age. a Publically available RNA-sequencing data sets from RGCs were assessed for expression of a subset of JNK signaling pathway genes implicated in axon injury. RGCs from a group of D2 eyes with ocular hypertension, but not optic nerve damage were compared with RGCs from control D2-Gpnmb+ eyes that do not have high intraocular pressure or develop glaucoma. The D2 eyes analyzed here belong to the group of eyes with the earliest detected changes in this model (Group 2,29). The Tukey-style box plots were generated in R. The thick bar represents median expression level and the hinges correspond to the first and third quartiles. Whiskers represent 1.5 × the interquartile range, with outlying data points plotted individually. Expression level is shown as log counts per million (log2CPM). Significant differences in expression of Jnk2 and Jun were detected. b Phosphorylated S63 pan-JNK immunoreactivity (pJNK, red) in ocular hypertensive (D2) and normotensive (D2-Gpnmb+) eyes was assessed by fluorescence in cross-sections that include the retina and the optic nerve head (ONH). The nerve fiber layer (NFL) is filled by RGC axons as they extend toward the ONH. DAPI (blue) labeling of nuclei was used as a counterstain. c Phosphorylated JUN immunoreactivity (pJUN, red) in the ganglion cell layer was assessed by fluorescence in retinal flat mounts with DAPI (blue) used as a counterstain. Representative images from ocular hypertensive (D2) and normotensive (D2-Gpnmb+) eyes are shown. *FDR < 0.05. Scale bar: 50 μm b, 25 μm c
Fig. 1 JNK pathway genes associated with axon injury in RGCs are expressed and activated during D2 glaucoma at 9 months of age. a Publically available RNA-sequencing data sets from RGCs were assessed for expression of a subset of JNK signaling pathway genes implicated in axon injury. RGCs from a group of D2 eyes with ocular hypertension, but not optic nerve damage were compared with RGCs from control D2-Gpnmb+ eyes that do not have high intraocular pressure or develop glaucoma. The D2 eyes analyzed here belong to the group of eyes with the earliest detected changes in this model (Group 2,29). The Tukey-style box plots were generated in R. The thick bar represents median expression level and the hinges correspond to the first and third quartiles. Whiskers represent 1.5 × the interquartile range, with outlying data points plotted individually. Expression level is shown as log counts per million (log2CPM). Significant differences in expression of Jnk2 and Jun were detected. b Phosphorylated S63 pan-JNK immunoreactivity (pJNK, red) in ocular hypertensive (D2) and normotensive (D2-Gpnmb+) eyes was assessed by fluorescence in cross-sections that include the retina and the optic nerve head (ONH). The nerve fiber layer (NFL) is filled by RGC axons as they extend toward the ONH. DAPI (blue) labeling of nuclei was used as a counterstain. c Phosphorylated JUN immunoreactivity (pJUN, red) in the ganglion cell layer was assessed by fluorescence in retinal flat mounts with DAPI (blue) used as a counterstain. Representative images from ocular hypertensive (D2) and normotensive (D2-Gpnmb+) eyes are shown. *FDR < 0.05. Scale bar: 50 μm b, 25 μm cCC BY · PubMed Central
Fig. 2 Jnk genotype has no affect on iris disease. Images of eyes were taken using a slit lamp biomicroscope. a Representative broad beam images demonstrating similar iris abnormalities in mice of all genotypes. b Representative images demonstrating the similar transillumination defects resulting from iris depigmentation in D2, D2.Jnk2−/−, and D2.Jnk3−/− mice
Fig. 2 Jnk genotype has no affect on iris disease. Images of eyes were taken using a slit lamp biomicroscope. a Representative broad beam images demonstrating similar iris abnormalities in mice of all genotypes. b Representative images demonstrating the similar transillumination defects resulting from iris depigmentation in D2, D2.Jnk2−/−, and D2.Jnk3−/− miceCC BY · PubMed Central
Fig. 3 Deficiency of Jnk2 or Jnk3 does not alter intraocular pressure profiles in D2 mice. IOP elevation occurs in Jnk2 and Jnk3-deficient mice at 8.5 mos a, 10.0 mos b, and 12.0 mos c. IOP elevations sufficient to cause glaucoma were observed in mice of all genotypes. No significant differences were found when comparing Jnk-deficient with control D2 mice (n = 40 per group, P > 0.05 in each comparison. However, at 12 mos Jnk2-deficient mice tended to have lower IOP than controls (n = 42, P = 0.052). IOP levels start to decline in D2 mice at 12 mos due to ciliary body degeneration and decreased production of aqueous humor. These data do not exclude a role for JNK2 in lessening this late disease process in the ciliary body, but this IOP difference may also be due to chance variation. In the boxplot, the boxes define the 25th and 75th percentiles. The black line in each box represents the median value. The red diamonds indicate the mean value and the 95% CI. The full range of the data points is also depicted
Fig. 3 Deficiency of Jnk2 or Jnk3 does not alter intraocular pressure profiles in D2 mice. IOP elevation occurs in Jnk2 and Jnk3-deficient mice at 8.5 mos a, 10.0 mos b, and 12.0 mos c. IOP elevations sufficient to cause glaucoma were observed in mice of all genotypes. No significant differences were found when comparing Jnk-deficient with control D2 mice (n = 40 per group, P > 0.05 in each comparison. However, at 12 mos Jnk2-deficient mice tended to have lower IOP than controls (n = 42, P = 0.052). IOP levels start to decline in D2 mice at 12 mos due to ciliary body degeneration and decreased production of aqueous humor. These data do not exclude a role for JNK2 in lessening this late disease process in the ciliary body, but this IOP difference may also be due to chance variation. In the boxplot, the boxes define the 25th and 75th percentiles. The black line in each box represents the median value. The red diamonds indicate the mean value and the 95% CI. The full range of the data points is also depictedCC BY · PubMed Central
Fig. 4 Histological assessment of retina and optic nerve. Representative images from H&E-stained ocular cross-sections and PPD stained optic nerves are shown for unaffected eyes (6 months of age) a, and severely affected eyes (12 months of age) b. These images demonstrate the hallmark degenerative features of glaucoma including RGC layer (GCL) neuron loss in the retina, nerve fiber layer thinning (compare arrowheads in a and b), optic disc cupping (arrow), and sick and degenerating axons (darkly stained dots), axon loss and glial scarring (asterisks) in the optic nerve. Scale bars: 50 μm (retina), 100 μm (optic nerve head), 25 μm (optic nerve)
Fig. 4 Histological assessment of retina and optic nerve. Representative images from H&E-stained ocular cross-sections and PPD stained optic nerves are shown for unaffected eyes (6 months of age) a, and severely affected eyes (12 months of age) b. These images demonstrate the hallmark degenerative features of glaucoma including RGC layer (GCL) neuron loss in the retina, nerve fiber layer thinning (compare arrowheads in a and b), optic disc cupping (arrow), and sick and degenerating axons (darkly stained dots), axon loss and glial scarring (asterisks) in the optic nerve. Scale bars: 50 μm (retina), 100 μm (optic nerve head), 25 μm (optic nerve)CC BY · PubMed Central
Fig. 5 Jnk2 deficiency increases optic nerve vulnerability to high IOP. The severity of optic nerve damage was determined using PPD stained cross-sections (see Materials and methods for details) at 9–10 mos a, > 10–11 mos b, and 12–13 mos c. Nerves were determined to have no glaucomatous nerve damage (no or early, NOE—no glaucoma based on nerve damage but called NOE as some of these eyes have early transcriptional changes that precede degeneration30), moderate disease (MOD) or severe disease (SEV). An increased number of eyes from Jnk2 mice had glaucomatous nerve damage compared with control D2 mice at 9.5 and 10.5 mos. ***P < 1 × 10−5
Fig. 5 Jnk2 deficiency increases optic nerve vulnerability to high IOP. The severity of optic nerve damage was determined using PPD stained cross-sections (see Materials and methods for details) at 9–10 mos a, > 10–11 mos b, and 12–13 mos c. Nerves were determined to have no glaucomatous nerve damage (no or early, NOE—no glaucoma based on nerve damage but called NOE as some of these eyes have early transcriptional changes that precede degeneration30), moderate disease (MOD) or severe disease (SEV). An increased number of eyes from Jnk2 mice had glaucomatous nerve damage compared with control D2 mice at 9.5 and 10.5 mos. ***P < 1 × 10−5CC BY · PubMed Central
Fig. 6 Jnk3 deficiency subtly exacerbates glaucoma in mice lacking Jnk2. a–c IOP elevations sufficient to cause glaucoma occurred for both genotypes with no significant differences between genotypes at 8 and 10.5 mos. At 12 mos, the difference between Jnk2−/− and Jnk2−/− Jnk3−/− genotypes was due to the IOP decrease observed in Jnk2 only deficient mice (P = 0.042). The IOP levels in mice with combined Jnk2 and 3 deficiencies closely resembled those of wild-type, heterozygous, and Jnk3-deficient mice (compare with Fig. 3c). Thus, the greater decrease in IOP in the Jnk2−/− mice may be due to chance, as it is hard to reconcile why the additional deficiency of Jnk3 in Jnk2−/− Jnk3−/− mutant mice would prevent it. d-f The severity of optic nerve damage was determined using PPD stained cross-sections (see Materials and methods for details). Data for D2.Jnk2−/− mice are the same data as in Fig. 5 as mice of all genotypes were produced in the same litters and examined at the same time
Fig. 6 Jnk3 deficiency subtly exacerbates glaucoma in mice lacking Jnk2. a–c IOP elevations sufficient to cause glaucoma occurred for both genotypes with no significant differences between genotypes at 8 and 10.5 mos. At 12 mos, the difference between Jnk2−/− and Jnk2−/− Jnk3−/− genotypes was due to the IOP decrease observed in Jnk2 only deficient mice (P = 0.042). The IOP levels in mice with combined Jnk2 and 3 deficiencies closely resembled those of wild-type, heterozygous, and Jnk3-deficient mice (compare with Fig. 3c). Thus, the greater decrease in IOP in the Jnk2−/− mice may be due to chance, as it is hard to reconcile why the additional deficiency of Jnk3 in Jnk2−/− Jnk3−/− mutant mice would prevent it. d-f The severity of optic nerve damage was determined using PPD stained cross-sections (see Materials and methods for details). Data for D2.Jnk2−/− mice are the same data as in Fig. 5 as mice of all genotypes were produced in the same litters and examined at the same timeCC BY · PubMed Central
Fig. 7 JNK2 and JNK3 are not necessary for RGC somal degeneration in glaucoma. a The JNK target JUN is known to promote RGC apoptosis in D2 glaucoma15. Double deficiency of Jnk2 and Jnk3 did not prevent accumulation of phosphorylated JUN (pJUN) immunoreactivity (red) at 10 mos. pJUN was detected by immunofluorescence in retinal flat mounts. b β-Tubulin is an RGC-specific marker in the retina and was used to label RGCs in retinal flat mounts at 12 mos. Representative images show loss of RGCs in eyes with severe optic nerve degeneration compared with healthy (NOE) eyes. Occasional RGCs have higher β-tubulin immunoreactivity (bright cells). c Quantification of β-tubulin-positive cells suggests that Jnk2 and Jnk3 deficiency did not affect somal degeneration of RGCs in eyes with severe optic nerve loss. RGC counts were similar in NOE eyes for all genotypes (represented together as All)
Fig. 7 JNK2 and JNK3 are not necessary for RGC somal degeneration in glaucoma. a The JNK target JUN is known to promote RGC apoptosis in D2 glaucoma15. Double deficiency of Jnk2 and Jnk3 did not prevent accumulation of phosphorylated JUN (pJUN) immunoreactivity (red) at 10 mos. pJUN was detected by immunofluorescence in retinal flat mounts. b β-Tubulin is an RGC-specific marker in the retina and was used to label RGCs in retinal flat mounts at 12 mos. Representative images show loss of RGCs in eyes with severe optic nerve degeneration compared with healthy (NOE) eyes. Occasional RGCs have higher β-tubulin immunoreactivity (bright cells). c Quantification of β-tubulin-positive cells suggests that Jnk2 and Jnk3 deficiency did not affect somal degeneration of RGCs in eyes with severe optic nerve loss. RGC counts were similar in NOE eyes for all genotypes (represented together as All)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 1

  1. Smith R. S. et al. in Systemic evaluation of the mouse eye (ed Smith R. S.) 265-297 (CRC Boca Raton, Florida Press, 2002).

Cited by

See all 23

Metadata

Authors
Harder, J. M., Williams, P. A., Soto, I., Foxworth, N. E., Fernandes, K. A., Freeburg, N. F., Libby, R. T., & John, S. W. M.
Affiliations
  • Jackson Laboratory (US)
  • Rowan University (US)
  • University of Rochester Medicine (US)
  • Tufts University (US)
Corresponding author
  • Libby, Richard T.
  • John, Simon. W. M.
Venue
Cell Death & Disease
Published
2018-06-13
Volume
9
Issue
6
Pages
705-705
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2808390585
Cited by
23
References
47
Citations by year
2026: 3 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 6 · 2020: 3 · 2019: 1
FWCI
2.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by)
Funders
  • Howard Hughes Medical Institute
  • Research to Prevent Blindness
  • Glaucoma Foundation
  • University of Rochester
  • Partridge Foundation
  • Medical Center, University of Rochester
  • National Eye Institute (R01EY027701, R01EY018606)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD007065)
Topics
  • Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
JNK2, JNK3, JNK1, glaucoma, retinal ganglion cell death, ocular hypertension, DBA/2J mice, c-Jun, neurodegeneration, intraocular pressure, optic nerve injury, JNK inhibitor, neuroprotection
MeSH terms
Animals, Axons, Enzyme Activation, Gene Expression Regulation, Glaucoma, Intraocular Pressure, Mice, Inbred DBA, Nerve Degeneration, Ocular Hypertension, Optic Nerve, Retina, Retinal Ganglion Cells, Cell Death, Mitogen-Activated Protein Kinase 9, Mitogen-Activated Protein Kinase 10

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice. https://app.cochat.ai/papers/10.1038/s41419-018-0705-8
The paper
Harder, J. M., Williams, P. A., Soto, I., Foxworth, N. E., Fernandes, K. A., Freeburg, N. F., Libby, R. T., & John, S. W. M. (2018). Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice. Cell Death & Disease. https://doi.org/10.1038/s41419-018-0705-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.